Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Six Phase I/II clinical trials enrolling approximately 900 participants confirmed an excellent safety profile with no serious adverse events attributed to the compound
Istraivanja su pokazala njegovu sposobnost da pomae kod breg zarastanja opekotina na koi tako to poveava protok krvi u oteena tkiva
Human studies mainly used short-term intravenous DSIP injections under controlled research conditions, typically at 25 nmol/kg, but these studies were small, short-duration, and not designed to establish long-term safety or optimal dosing
However, it is also a very important oxidation-regulating compound, thus melanin serves as a protective mechanism against UV exposure
